DEA Sued By Rhode Island Lab Over ‘Foot Dragging’ On Marijuana Pharmaceutical Licensing, Here’s What We Know So Far

The companies behind the lawsuit are seeking to compel the DEA to act on their applications for bulk manufacturing and importing of specific strains of marijuana to treat two degenerative diseases.

Two Rhode Island cannabinoid research laboratories are suing the DEA for standing in the way of what they consider to be the crucial development of pharmaceutical-grade cannabis products for use in clinical trials for the treatment of Multiple Sclerosis and Huntington’s Disease.

The companies argue that the DEA has long passed the deadlines to issue a decision and has delayed progress from the beginning, say scientists from the labs in question: MMJ BioPharma Cultivation Inc., and MMJ International Holdings Corp., which now say it’s time for legal action.

– Read the entire article at Benzinga.

Read More Here...

Leave a Reply

Your email address will not be published.